[Updated on Apr. 18] Integration of CiNii Articles into CiNii Research

Time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and in healthy volunteers

Bibliographic Information

Other Title
  • Sonazoid造影超音波検査における門脈内Sonazoid停滞時間に関する検討

Search this article

Abstract

Sonazoid, an ultrasonography contrast agent which consists of perflubutane microbubbles with shells, is stable in blood vessels and remains for a long time. We investigated time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and healthy volunteers. Among 25 patients with chronic liver disease, Sonazoid remained at the rates of 54.8±15.2%, 32.5±13.3%, 25.2±12.2%, 8.8±7.1% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. In healthy volunteers, Sonazoid remained at the rates of 60.1±12.9%, 41.4±11.4%, 32.0±10.3%, 7.8±4.5% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. It is recommended that Kupffer images of Sonazoid-enhanced contrast ultrasonography is evaluated 60 minutes after injection of Sonazoid to avoid an influence of sonazoid remaining in the vessels.<br>

Journal

  • Kanzo

    Kanzo 50 (10), 593-594, 2009

    The Japan Society of Hepatology

Citations (3)*help

See more

References(7)*help

See more

Related Articles

See more

Related Data

See more

Related Books

See more

Related Dissertations

See more

Related Projects

See more

Related Products

See more

Details

Report a problem

Back to top